Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
D000911:Antibodies, Monoclonal; D002278:Carcinoma in Situ / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D018450:Disease Progression; D005260:Female; D005805:Genes, MHC Class I; D005802:Genes, MHC Class II; D006680:HLA Antigens / Q000032:analysis*; D015235:HLA-B Antigens / Q000032:analysis; D015395:Histocompatibility Antigens Class I / Q000032:analysis*; D000949:Histocompatibility Antigens Class II / Q000032:analysis*; D006801:Humans; D007150:Immunohistochemistry; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology